View Item 

Show simple item record

No End in Sight: Benzodiazepine Use in Older Adults in the United States
dc.contributor.authorMaust, Donovan T.
dc.contributor.authorKales, Helen C.
dc.contributor.authorWiechers, Ilse R.
dc.contributor.authorBlow, Frederic C.
dc.contributor.authorOlfson, Mark
dc.date.accessioned2017-01-10T19:09:06Z
dc.date.available2018-02-01T14:56:11Zen
dc.date.issued2016-12
dc.identifier.citationMaust, Donovan T.; Kales, Helen C.; Wiechers, Ilse R.; Blow, Frederic C.; Olfson, Mark (2016). "No End in Sight: Benzodiazepine Use in Older Adults in the United States." Journal of the American Geriatrics Society 64(12): 2546-2553.
dc.identifier.issn0002-8614
dc.identifier.issn1532-5415
dc.identifier.urihttps://hdl.handle.net/2027.42/135540
dc.publisherAmerican Psychiatric Association
dc.publisherWiley Periodicals, Inc.
dc.subject.otheranxiety
dc.subject.otherinsomnia
dc.subject.otherpsychotropic
dc.subject.otherbenzodiazepine
dc.titleNo End in Sight: Benzodiazepine Use in Older Adults in the United States
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelGeriatrics
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/135540/1/jgs14379_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/135540/2/jgs14379.pdf
dc.identifier.doi10.1111/jgs.14379
dc.identifier.sourceJournal of the American Geriatrics Society
dc.identifier.citedreferenceCovin R, Ouimet AJ, Seeds PM et al. A meta‐analysis of CBT for pathological worry among clients with GAD. J Anxiety Disord 2008; 22: 108 – 116.
dc.identifier.citedreferenceGleason PP, Schulz R, Smith NL et al. Correlates and prevalence of benzodiazepine use in community‐dwelling elderly. J Gen Intern Med 1998; 13: 243 – 250.
dc.identifier.citedreferenceSimon GE, Vonkorff M, Barlow W et al. Predictors of chronic benzodiazepine use in a health maintenance organization sample. J Clin Epidemiol 1996; 49: 1067 – 1073.
dc.identifier.citedreferenceNational Center for Health Statistics, Centers for Disease Control and Prevention. About the ambulatory health care surveys: National Ambulatory Medical Care Survey [on‐line]. Available at http://www.cdc.gov/nchs/ahcd/about_ahcd.htm Accessed December 12, 2013.
dc.identifier.citedreferenceNational Center for Health Statistics, Centers for Disease Control and Prevention. National Ambulatory Medical Care Survey: 2010 NAMCS Micro‐data file documentation [on‐line]. Available at ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NAMCS/doc2010 Accessed December 12, 2013.
dc.identifier.citedreferenceSchneider D, Appleton L, McLemore T. A reason for visit classification for ambulatory care. Vital Health Stat 2 1979; 78: i – vi, 1–63.
dc.identifier.citedreferenceHsiao C‐J. National Center for Health Statistics, Centers for Disease Control and Prevention. Understanding and using NAMCS and NHAMCS data: Data tools and basic programming techniques [on‐line]. Available at http://www.cdc.gov/nchs/ppt/nchs2010/03_Hsiao.pdf Accessed December 12, 2013.
dc.identifier.citedreferenceU.S. Census Bureau, U.S. Department of Commerce. Population Estimates: Population and Housing Unit Estimates. Available at http://www.census.gov/popest/index.html Accessed December 12, 2013.
dc.identifier.citedreferenceGould RL, Coulson MC, Howard RJ. Efficacy of cognitive behavioral therapy for anxiety disorders in older people: A meta‐analysis and meta‐regression of randomized controlled trials. J Am Geriatr Soc 2012; 60: 218 – 229.
dc.identifier.citedreferenceWetherell JL, Lenze EJ, Stanley MA. Evidence‐based treatment of geriatric anxiety disorders. Psychiatr Clin North Am 2005; 28: 871 – 896.
dc.identifier.citedreferenceLeichsenring F, Salzer S, Jaeger U et al. Short‐term psychodynamic psychotherapy and cognitive‐behavioral therapy in generalized anxiety disorder: A randomized, controlled trial. Am J Psychiatry 2009; 166: 875 – 881.
dc.identifier.citedreferenceOlfson M, Marcus SC, Druss B et al. National trends in the use of outpatient psychotherapy. Am J Psychiatry 2002; 159: 1914 – 1920.
dc.identifier.citedreferencePractice Guideline for the Treatment of Patients with Panic Disorder. Washington, DC: American Psychiatric Association, 2010 [on‐line]. Available at http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/panicdisorder.pdf Accessed June 20, 2015.
dc.identifier.citedreferenceBandelow B, Zohar J, Hollander E et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive‐compulsive and post‐traumatic stress disorders–first revision. World J Biol Psychiatry 2008; 9: 248 – 312.
dc.identifier.citedreferenceWright RM, Roumani YF, Boudreau R et al. Effect of central nervous system medication use on decline in cognition in community‐dwelling older adults: Findings from the Health, Aging and Body Composition Study. J Am Geriatr Soc 2009; 57: 243 – 250.
dc.identifier.citedreferenceMiller M, Stürmer T, Azrael D et al. Opioid analgesics and the risk of fractures in older adults with arthritis. J Am Geriatr Soc 2011; 59: 430 – 438.
dc.identifier.citedreferenceJones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA 2013; 309: 657 – 659.
dc.identifier.citedreferenceKunik ME, Roundy K, Veazey C et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest 2005; 127: 1205 – 1211.
dc.identifier.citedreferenceEkström MP, Bornefalk‐Hermansson A, Abernethy AP et al. Safety of benzodiazepines and opioids in very severe respiratory disease: National prospective study. BMJ 2014; 348: g445.
dc.identifier.citedreferenceEgan M, Moride Y, Wolfson C et al. Long‐term continuous use of benzodiazepines by older adults in Quebec: Prevalence, incidence and risk factors. J Am Geriatr Soc 2000; 48: 811 – 816.
dc.identifier.citedreferenceTannenbaum C, Martin P, Tamblyn R et al. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education. JAMA Intern Med 2014; 174: 890 – 898.
dc.identifier.citedreferenceBishop TF, Press MJ, Keyhani S et al. Acceptance of insurance by psychiatrists and the implications for access to mental health care. JAMA Psychiatry 2014; 71: 176 – 181.
dc.identifier.citedreferenceOlfson M, King M, Schoenbaum M. Benzodiazepine use in the United States. JAMA Psychiatry 2015; 72: 136 – 142.
dc.identifier.citedreferenceBaldwin D, Woods R, Lawson R et al. Efficacy of drug treatments for generalised anxiety disorder: Systematic review and meta‐analysis. BMJ 2011; 342: d1199.
dc.identifier.citedreferenceSmith MT, Perlis ML, Park A et al. Comparative meta‐analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 2014; 159: 5 – 11.
dc.identifier.citedreferenceWu JQ, Appleman ER, Salazar RD et al. Cognitive behavioral therapy for insomnia comorbid with psychiatric and medical conditions: A meta‐analysis. JAMA Intern Med 2015; 175: 1461 – 1472.
dc.identifier.citedreferenceWoolcott JC, Richardson KJ, Wiens MO et al. Meta‐analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 2009; 169: 1952 – 1960.
dc.identifier.citedreferenceWang PS, Bohn RL, Glynn RJ et al. Hazardous benzodiazepine regimens in the elderly: Effects of half‐life, dosage, and duration on risk of hip fracture. Am J Psychiatry 2001; 158: 892 – 898.
dc.identifier.citedreferenceDassanayake T, Michie P, Carter G et al. Effects of benzodiazepines, antidepressants and opioids on driving. Drug Saf 2011; 34: 125 – 156.
dc.identifier.citedreferenceTannenbaum C, Paquette A, Hilmer S et al. A systematic review of amnestic and non‐amnestic mild cognitive impairment induced by anticholinergic, antihistamine. GABAergic and opioid drugs. Drugs Aging 2012; 29: 639 – 658.
dc.identifier.citedreferencePaterniti S, Dufouil C, Alpérovitch A. Long‐term benzodiazepine use and cognitive decline in the elderly: The Epidemiology of Vascular Aging Study. J Clin Psychopharmacol 2002; 22: 285 – 293.
dc.identifier.citedreferenceBillioti de Gage S, Moride Y, Ducruet T et al. Benzodiazepine use and risk of Alzheimer’s disease: Case‐control study. BMJ 2014; 349: g5205.
dc.identifier.citedreferenceAmerican Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc 2015; 63: 2227 – 2246.
dc.identifier.citedreferenceAmerican Geriatrics Society. Choosing wisely website. Ten things physicians and patients should question [on‐line]. Available at http://www.choosingwisely.org/societies/american-geriatrics-society/Accessed July 13, 2015.
dc.identifier.citedreferenceCook JM, Biyanova T, Masci C et al. Older patient perspectives on long‐term anxiolytic benzodiazepine use and discontinuation: A qualitative study. J Gen Intern Med 2007; 22: 1094 – 1100.
dc.identifier.citedreferenceCook JM, Marshall R, Masci C et al. Physicians’ perspectives on prescribing benzodiazepines for older adults: A qualitative study. J Gen Intern Med 2007; 22: 303 – 307.
dc.identifier.citedreferenceSimon GE, Ludman EJ. Outcome of new benzodiazepine prescriptions to older adults in primary care. Gen Hosp Psychiatry 2006; 28: 374 – 378.
dc.identifier.citedreferenceMaust DT, Mavandadi S, Eakin A et al. Telephone‐based behavioral health assessment for older adults starting a new psychiatric medication. Am J Geriatr Psychiatry 2011; 19: 851 – 858.
dc.identifier.citedreferenceGould RL, Coulson MC, Patel N et al. Interventions for reducing benzodiazepine use in older people: Meta‐analysis of randomised controlled trials. Br J Psychiatry 2014; 204: 98 – 107.
dc.identifier.citedreferenceBaillargeon L, Landreville P, Verreault R et al. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive‐behavioural therapy combined with gradual tapering: A randomized trial. Can Med Assoc J 2003; 169: 1015 – 1020.
dc.identifier.citedreferenceMorin C, Bastien C, Guay B et al. Insomnia and chronic use of benzodiazepines: A randomized clinical trial of supervised tapering, cognitive‐behavior therapy, and a combined approach to facilitate benzodiazepine discontinuation. Am J Psychiatry 2004; 161: 332 – 342.
dc.identifier.citedreferenceGray SL, Eggen AE, Blough D et al. Benzodiazepine use in older adults enrolled in a health maintenance organization. Am J Geriatr Psychiatry 2003; 11: 568 – 576.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jgs14379_am.pdf
Size:
201.5KB
Format:
PDF
View/Open
Name:
jgs14379.pdf
Size:
123.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.